Essential hypertension Trials in Shanghai, China
Conditions / Essential hypertension / Shanghai, China
Clinical trials for Essential hypertension investigate a range of treatment strategies and patient populations.
13 total trials for this combination
Showing top 10 of 13 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00856271 | Olmesartan Medoxomil Versus Losartan Potassium in Patients With Mild to Moderate Essential Hypertension | COMPLETED | PHASE3 |
| NCT01785472 | Efficacy and Safety of LCZ696 in Comparison to Olmesartan in Asian Patients With Essential Hypertension | COMPLETED | PHASE3 |
| NCT01615198 | Efficacy and Safety of LCZ696 in Comparison to Olmesartan in Elderly Patients With Essential Hypertension | COMPLETED | PHASE3 |
| NCT01848873 | Efficacy of Amlodipine-folic Acid Tablets on Reduction of Blood Pressure and Plasma Homocysteine | UNKNOWN | PHASE2/PHASE3 |
| NCT02480764 | Azilsartan Medoxomil (TAK-491) Compared to Valsartan in Chinese Participants With Hypertension | COMPLETED | PHASE3 |
| NCT01663233 | Efficacy and Safety of LCZ696 200 mg + Amlodipine 5 mg in Comparison With Amlodipine 5 mg in Hypertensive Patients Not Responding to Amlodipine | COMPLETED | PHASE3 |
| NCT01956786 | Efficacy of Amlodipine-Folic Acid Tablets on Reduction of Blood Pressure and Plasma Homocysteine | UNKNOWN | PHASE2/PHASE3 |
| NCT00872586 | Evaluation of the Additional Efficacy, and Safety of Olmesartan Medoxomil 20mg / Hydrochlorothiazide 12.5mg in the Treatment of Chinese Patients With Mild to Moderate Essential Hypertension | COMPLETED | PHASE3 |
| NCT05359068 | Study to Evaluate the Efficacy and Safety of SPH3127 In Patients With Mild-moderate Essential Hypertension | COMPLETED | PHASE3 |
| NCT07051811 | To Evaluate the Safety and Efficacy of a Single-Use IVUS Ablation for Primary Hypertension | RECRUITING | NA |